BP-897

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBP-897
Drug Alias NameBP-897DO-897BP-4.897
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsCocaine-Related DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioprojet Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioprojet Pharma
Active IndicationsN/A
Inactive IndicationsCocaine-Related DisordersParkinson Disease

Other Information

ATC CodeN/A
Related LinksWikipedia